Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pantothenate kinase 3 is an enzyme that catalyzes the first, rate-limiting step in the biosynthesis of coenzyme A (CoA) by phosphorylating pantothenate (vitamin B5) to form 4'-phosphopantothenate using ATP. It is one of four pantothenate kinase isoforms in humans and is most abundantly expressed in the liver. By regulating the cellular levels of CoA, pantothenate kinase 3 plays a critical role in metabolic processes including fatty acid oxidation, the citric acid cycle, and amino acid metabolism. Genetic defects in related pathways are associated with neurodegenerative disorders, although disease association with PANK3 specifically is less direct than for PANK2[1][3][6][7].
Inhibitors or modulators would alter CoA biosynthesis by affecting the phosphorylation of pantothenate, thereby influencing metabolic pathways that depend on CoA availability[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pantothenate kinase 3 (PANK3).